9:25 AM ET
Earnings Call
▶ Call
Xeris Biopharma Holdings Earnings Call: Key Takeaways
Xeris Biopharma delivered a strong Q3 with 44% revenue growth, significantly raising 2030 revenue targets to over $1 billion driven by Recorlev momentum.
- Call
- Nov 5, 2026, 8:30 AM ET